NextFin News - Truist’s sector call on financials and healthcare lands at a moment when the market is no longer rewarding only the AI trade. The sharper question is not whether tech still matters — it does — but whether the rally is becoming broad enough to survive a pause in the megacap group. Recent market signals say that breadth is improving: Asia stocks rallied after cooler U.S. inflation data scaled back expectations for more Fed tightening, South Korea’s KOSPI jumped 7%, and global equity funds drew $12.46 billion in inflows for an eighth straight week through July 15. That is the setting in which financials and healthcare are starting to look less like defensive afterthoughts and more like the next place investors are willing to hide and hunt for returns.
The significance of the call lies in what these sectors represent. Financials are the market’s read-through on credit, capital-markets activity, and the slope of the rate path. Healthcare is the market’s read-through on reimbursement, policy risk, and stable earnings power. When both are attracting attention at the same time, the message is not that one economic story has ended and another has begun. It is that investors want a wider earnings base, and they are beginning to test how far the rally can travel beyond a narrow set of leaders.
That does not make the rotation a done deal. It does, however, suggest that breadth is becoming a theme in its own right. UBS Global Wealth Management’s James Cheo put the shift plainly on July 7, saying that sectors beyond AI “such as healthcare, financials, and industrials are beginning to pick up.” That matters because it frames the current move as participation broadening, not a wholesale rejection of growth. The AI trade can still work. But if other sectors start contributing more consistently, index returns no longer depend so heavily on a handful of large technology names.
What The Broadening Rally Is Actually Saying
The first read is cyclical. Cooler inflation has reduced pressure on rates, and that alone can change how investors allocate risk. When the market stops worrying that policy will tighten further, it becomes easier to own sectors that had lagged on valuation or uncertainty. That is exactly the sort of backdrop in which financials and healthcare can improve at the same time: one group benefits from activity and rates, the other from resilience and policy stability.
But there is a second layer. Broadening is not just about relief after a concentrated rally; it also reflects where fresh earnings support is still available. In a market where megacap technology has already done a great deal of the heavy lifting, analysts begin looking for sectors where estimates have room to move. Truist’s own work in July pointed to that logic from a different angle. The firm’s higher quarterly profit on July 17 was helped by a rebound in capital-markets activity and stronger trading, which shows why financials can regain favor when volatility and deal flow improve. The same logic helps explain why healthcare can attract attention: investors often turn to it when they want earnings streams that are not tied to the same AI spending cycle driving the biggest stocks.
The market’s second-order reaction matters more than the first-order one. The obvious effect of a broader rally is that more stocks go up. The less obvious effect is that benchmark performance becomes less fragile. When index gains are concentrated, a stumble in a few giant stocks can drag the whole market. When breadth improves, those same disappointments matter less because other sectors are contributing. That can change how investors interpret even neutral data. A mild inflation print, for example, does not just help rate-sensitive groups; it also tells the market that the macro backdrop is not actively working against non-tech leadership.
The recent flow data fit that interpretation. LSEG Lipper data showed global equity funds taking in $12.46 billion for the week through July 15, the eighth consecutive week of inflows, as cooler U.S. inflation data eased expectations of Fed rate hikes. That is not a marginal signal. It says capital is still willing to move into risk assets even as leadership rotates. In a breadth environment, that matters because fresh inflows can support a wider set of names instead of simply reinforcing the largest index weights.
“Sectors beyond AI such as healthcare, financials, and industrials are beginning to pick up,” James Cheo, chief investment officer for Southern Asia and Australia at UBS Global Wealth Management, said on July 7.
Why Financials And Healthcare Can Rise Together
Can two sectors with such different drivers both be a sign of the same market mood? Yes, because the common denominator is not sector similarity. It is the market’s desire for a broader set of earnings contributors. Financials respond to the pace of activity, to capital-markets pipelines, and to whether rate expectations are still rising or have begun to settle. Healthcare responds to whether policy and reimbursement risk look manageable enough to support stable growth. When those two groups are both gaining favor, investors are effectively saying they want a market that can broaden without breaking.
That is why the current call looks more cyclical than structural. A structural regime change would require evidence that the market has permanently moved away from a tech-led earnings model because rules, industry structure, or capital allocation have changed in a lasting way. That evidence is not here yet. There has been no sweeping policy shift in healthcare, no durable redesign of bank profitability, and no sign that the dominant technology names have lost their long-term earnings power. Instead, the move still looks like a rotation within an existing bull market — one driven by valuation, lower inflation, and investors’ willingness to extend risk to places that had been left behind.
That cyclical reading is consistent with the historical pattern of broadening rallies. When inflation cools and the rate path becomes less threatening, lagging sectors often catch up. The move can last for months, sometimes longer, but it typically requires continued macro support. Once the valuation gap closes, breadth needs fresh earnings surprises to keep going. If those surprises do not arrive, leadership can quickly re-concentrate back into the largest growth names.
The strongest counter-thesis is that this is the beginning of a more durable rebalancing in equity leadership. That view has support. AI-heavy positioning has become crowded, healthcare has a more constructive policy backdrop than it did a year ago, and financials can benefit from a market where capital-markets activity and trading volumes are no longer frozen. If the market is moving into a phase where multiple sectors can grow earnings at once, then breadth is not merely a cyclical pause; it is the next leg of the bull market.
But a structural thesis needs structural proof. The falsifying test for the cyclical view would be clear: if equal-weighted leadership continues to outperform cap-weighted benchmarks for several quarters and earnings revisions in financials and healthcare keep beating the market’s largest technology names, then the market is not just rotating. It is redefining where equity leadership lives.
For now, that is still a test, not a verdict.
What To Watch Next
The near-term beneficiaries are obvious. A broader rally helps sectors that had been ignored, gives active managers more room to generate alpha, and reduces the market’s dependence on a narrow set of megacap winners. Financials benefit if capital-markets activity stays alive and if the market stays comfortable with the path of rates. Healthcare benefits if policy risk remains contained and if earnings estimates keep moving in the right direction.
The exposed side is equally clear. If breadth is really just a lagging reaction to lower inflation, it can fade as quickly as it appeared. If the economy slows enough to hurt credit quality, financials can stop looking like catch-up beneficiaries and start looking like early warning indicators. If healthcare strength comes mostly from defensiveness rather than from better growth, it can hold up without leading. And if the AI trade regains control of index returns, the broadening narrative will again look more like a temporary side-rotation than a new regime.
The key checkpoints are the next inflation reads, the pace of earnings revisions, and whether equal-weighted market leadership continues to hold up against the cap-weighted index. A base case of continued breadth still looks most plausible. The upside case is a genuine multi-sector earnings expansion that keeps financials and healthcare bid even after valuations normalize. The downside case is a short-lived breadth trade that fades once the market returns to paying almost everything for AI exposure.
Truist’s call fits the first of those scenarios. It is a reminder that the rally can broaden, but not yet proof that leadership has changed for good.
This is not the market leaving tech behind. It is the market admitting that the rally needs more than tech to keep going.
Explore more exclusive insights at nextfin.ai.
